"DYRONIB" belongs to Tyrosine Kinase Inhibitor therapy of Oncology Division and it is available in 2 forms : Dyronib 50 mg Tablet and Dyronib 70 mg Tablet.
Copyright ©2025 All Rights Reserved by Hetero Healthcare Limited.